Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- Study of Dose Escalation of Liposomal Amikacin for Inhalation (ARIKAYCE™) – Extension Phase: Complete Statistical AnalysisIndependent statistical analysis of Study of Dose Escalation of Liposomal Amikacin for Inhalation (ARIKAYCE™) - Extension Phase: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Dose Escalation Versus no Dose Escalation of Imatinib in Metastatic Gastrointestinal Stromal Tumors (GIST) Patients: Complete Statistical AnalysisIndependent statistical analysis of Study of Dose Escalation Versus no Dose Escalation of Imatinib in Metastatic Gastrointestinal Stromal Tumors (GIST) Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study of Dovitinib and Biomarkers in Advanced Non-Small Cell Lung Cancer or Advanced Colorectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Dovitinib and Biomarkers in Advanced Non-Small Cell Lung Cancer or Advanced Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® PEDIATRICO in Argentinean Infants: Complete Statistical AnalysisIndependent statistical analysis of Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® PEDIATRICO in Argentinean Infants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of Dupilumab Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis: Complete Statistical AnalysisIndependent statistical analysis of Study of Dupilumab Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (LIBERTY-PN PRIME): Complete Statistical AnalysisIndependent statistical analysis of Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (LIBERTY-PN PRIME): primary endpoint…
- Study of Dupilumab in Adult Participants With Active Eosinophilic Esophagitis (EoE): Complete Statistical AnalysisIndependent statistical analysis of Study of Dupilumab in Adult Participants With Active Eosinophilic Esophagitis (EoE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of Durvalumab and Tremelimumab After Radiation for Microsatellite Stable Metastatic Colorectal Cancer Progressing on Chemotherapy: Complete Statistical AnalysisIndependent statistical analysis of Study of Durvalumab and Tremelimumab After Radiation for Microsatellite Stable Metastatic Colorectal Cancer Progressing on Chemotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of E7046 in Subjects With Selected Advanced Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Study of E7046 in Subjects With Selected Advanced Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02540291).
- Study of Efavaleukin Alfa in Healthy Chinese, Japanese, and Caucasian Participants: Complete Statistical AnalysisIndependent statistical analysis of Study of Efavaleukin Alfa in Healthy Chinese, Japanese, and Caucasian Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of Effectiveness and Safety of SD-101 in Participants With Epidermolysis Bullosa: Complete Statistical AnalysisIndependent statistical analysis of Study of Effectiveness and Safety of SD-101 in Participants With Epidermolysis Bullosa: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Adult Patients With Allergic Grass Pollen Rhinoconjunctivitis: Complete Statistical AnalysisIndependent statistical analysis of Study of Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Adult Patients With Allergic Grass Pollen Rhinoconjunctivitis: primary endpoint results, effect estimate with confidence interval,…
- Study of Efficacy and Safety of Canakinumab in Japanese Patients With SJIA: Complete Statistical AnalysisIndependent statistical analysis of Study of Efficacy and Safety of Canakinumab in Japanese Patients With SJIA: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma: Complete Statistical AnalysisIndependent statistical analysis of Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Previously Treated Patients With Metastatic, Radio-active Iodine Refractory BRAF V600E Mutation Positive Differentiated Thyroid Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Previously Treated Patients With Metastatic, Radio-active Iodine Refractory BRAF V600E Mutation Positive Differentiated Thyroid Cancer: primary…
- Study of Efficacy and Safety of Drugs BCD-033 and Rebif for Treatment of Patients With Multiple Sclerosis: Complete Statistical AnalysisIndependent statistical analysis of Study of Efficacy and Safety of Drugs BCD-033 and Rebif for Treatment of Patients With Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study of Efficacy and Safety of LOU064 in Inadequately Controlled Asthma Patients: Complete Statistical AnalysisIndependent statistical analysis of Study of Efficacy and Safety of LOU064 in Inadequately Controlled Asthma Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of Efficacy and Safety of NIS793 in Combination With Standard of Care (SOC) Chemotherapy in First-line Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) – daNIS-2: Complete Statistical AnalysisIndependent statistical analysis of Study of Efficacy and Safety of NIS793 in Combination With Standard of Care (SOC) Chemotherapy in First-line Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) - daNIS-2: primary endpoint results, effect…
- Study of Efficacy and Safety of Omalizumab in Severe Japanese Cedar Pollinosis Adult and Adolescent Patients: Complete Statistical AnalysisIndependent statistical analysis of Study of Efficacy and Safety of Omalizumab in Severe Japanese Cedar Pollinosis Adult and Adolescent Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment.: Complete Statistical AnalysisIndependent statistical analysis of Study of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment.: primary endpoint results, effect estimate with confidence interval,…
- Study of Efficacy and Safety of Reinfusion of Tisagenlecleucel in Pediatric and Young Adult Patients With Acute Lymphoblastic Leukemia (ALL): Complete Statistical AnalysisIndependent statistical analysis of Study of Efficacy and Safety of Reinfusion of Tisagenlecleucel in Pediatric and Young Adult Patients With Acute Lymphoblastic Leukemia (ALL): primary endpoint results, effect estimate with confidence interval,…
- Study of Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder: Complete Statistical AnalysisIndependent statistical analysis of Study of Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of Efficacy and Safety of Xolair® (Omalizumab) in Chinese Patients With Chronic Spontaneous Urticaria: Complete Statistical AnalysisIndependent statistical analysis of Study of Efficacy and Safety of Xolair® (Omalizumab) in Chinese Patients With Chronic Spontaneous Urticaria: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study of Efficacy, Safety and Tolerability of ACZ885 (Canakinumab) in Pediatric and Young Adult Patients With Sickle Cell Anemia: Complete Statistical AnalysisIndependent statistical analysis of Study of Efficacy, Safety and Tolerability of ACZ885 (Canakinumab) in Pediatric and Young Adult Patients With Sickle Cell Anemia: primary endpoint results, effect estimate with confidence interval, sample-size…
- Study of Efficacy, Safety and Tolerability of AIN457 in Patients With Active Overuse Tendinopathy: Complete Statistical AnalysisIndependent statistical analysis of Study of Efficacy, Safety and Tolerability of AIN457 in Patients With Active Overuse Tendinopathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of Efficacy, Safety, and Tolerability of LYS006, in Patients With Mild to Moderate Ulcerative Colitis: Complete Statistical AnalysisIndependent statistical analysis of Study of Efficacy, Safety, and Tolerability of LYS006, in Patients With Mild to Moderate Ulcerative Colitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of Efficacy, Safety, Tolerability and Pharmacokinetics of MIJ821 in Participants With Treatment- Resistant Depression (TRD): Complete Statistical AnalysisIndependent statistical analysis of Study of Efficacy, Safety, Tolerability and Pharmacokinetics of MIJ821 in Participants With Treatment- Resistant Depression (TRD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of Emerfetamab (AMG 673) in Adults With Relapsed/Refractory Acute Myeloid Leukemia (AML): Complete Statistical AnalysisIndependent statistical analysis of Study of Emerfetamab (AMG 673) in Adults With Relapsed/Refractory Acute Myeloid Leukemia (AML): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of ENMD-2076 in Patients With Advanced/Metastatic Soft Tissue Sarcoma: Complete Statistical AnalysisIndependent statistical analysis of Study of ENMD-2076 in Patients With Advanced/Metastatic Soft Tissue Sarcoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01719744).
- Study of Entinostat With Nivolumab Plus Ipilimumab in Previously Treated Renal Cell Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Study of Entinostat With Nivolumab Plus Ipilimumab in Previously Treated Renal Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Enzalutamide (Formerly MDV3100) as a Neoadjuvant Therapy for Patients Undergoing Prostatectomy for Localized Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Enzalutamide (Formerly MDV3100) as a Neoadjuvant Therapy for Patients Undergoing Prostatectomy for Localized Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study of Enzalutamide in Patients With Castration-resistant Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Enzalutamide in Patients With Castration-resistant Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01942837).
- Study of Epidural Steroid Injection (ESI) Versus Minimally Invasive Lumbar Decompression (Mild®) in Patients With Symptomatic Lumbar Central Canal Stenosis: Complete Statistical AnalysisIndependent statistical analysis of Study of Epidural Steroid Injection (ESI) Versus Minimally Invasive Lumbar Decompression (Mild®) in Patients With Symptomatic Lumbar Central Canal Stenosis: primary endpoint results, effect estimate with confidence interval,…
- Study of Eribulin Mesylate in Combination With PEGylated Recombinant Human Hyaluronidase (PEGPH20) Versus Eribulin Mesylate Alone in Subjects With Human Epidermal Growth Factor Receptor 2 (HER2)-Negative, High-Hyaluronan (HA) Metastatic Breast Cancer (MBC): Complete Statistical AnalysisIndependent statistical analysis of Study of Eribulin Mesylate in Combination With PEGylated Recombinant Human Hyaluronidase (PEGPH20) Versus Eribulin Mesylate Alone in Subjects With Human Epidermal Growth Factor Receptor 2 (HER2)-Negative, High-Hyaluronan (HA)…
- Study of Etanercept for the Prevention of Complications Resulting From Hematopoietic Stem Cell Transplantation (HSCT): Complete Statistical AnalysisIndependent statistical analysis of Study of Etanercept for the Prevention of Complications Resulting From Hematopoietic Stem Cell Transplantation (HSCT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study of Evacetrapib (LY2484595) and Warfarin in Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of Study of Evacetrapib (LY2484595) and Warfarin in Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02161731).
- Study of Everolimus (RAD001) in Combination With Lenalidomide: Complete Statistical AnalysisIndependent statistical analysis of Study of Everolimus (RAD001) in Combination With Lenalidomide: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01218555).
- Study of Everolimus (RAD001) in Patients With Recurrent Glioblastoma Multiforme (GBM): Complete Statistical AnalysisIndependent statistical analysis of Study of Everolimus (RAD001) in Patients With Recurrent Glioblastoma Multiforme (GBM): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of EXPAREL in Patients Undergoing Breast Augmentation: Complete Statistical AnalysisIndependent statistical analysis of Study of EXPAREL in Patients Undergoing Breast Augmentation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01582490).
- Study of Exparel Versus Epidural for Pain Control After Thoracotomy: Complete Statistical AnalysisIndependent statistical analysis of Study of Exparel Versus Epidural for Pain Control After Thoracotomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02178553).
- Study of Fampridine-SR Tablets in Multiple Sclerosis Patients: Complete Statistical AnalysisIndependent statistical analysis of Study of Fampridine-SR Tablets in Multiple Sclerosis Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00483652).
- Study of Favezelimab (MK-4280) as Monotherapy and in Combination With Pembrolizumab (MK-3475) With or Without Chemotherapy or Lenvatinib (MK-7902) AND Favezelimab/Pembrolizumab (MK-4280A) as Monotherapy in Adults With Advanced Solid Tumors (MK-4280-001): Complete Statistical AnalysisIndependent statistical analysis of Study of Favezelimab (MK-4280) as Monotherapy and in Combination With Pembrolizumab (MK-3475) With or Without Chemotherapy or Lenvatinib (MK-7902) AND Favezelimab/Pembrolizumab (MK-4280A) as Monotherapy in Adults With Advanced…
- Study of Fc-Optimized Anti-CD19 Antibody (MOR00208) to Treat B-cell Acute Lymphoblastic Leukemia(B-ALL): Complete Statistical AnalysisIndependent statistical analysis of Study of Fc-Optimized Anti-CD19 Antibody (MOR00208) to Treat B-cell Acute Lymphoblastic Leukemia(B-ALL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of Fentanyl-Propofol-EMLA of L.M.X4 Technique for Bone Marrow Aspiration: Complete Statistical AnalysisIndependent statistical analysis of Study of Fentanyl-Propofol-EMLA of L.M.X4 Technique for Bone Marrow Aspiration: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00187135).
- Study of Fixed-Dose Combinations of Trabodenoson and Latanoprost in Adults With OHT or POAG: Complete Statistical AnalysisIndependent statistical analysis of Study of Fixed-Dose Combinations of Trabodenoson and Latanoprost in Adults With OHT or POAG: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of Flexible Doses of the Triple Reuptake Inhibitor EB-1020 Sustained Release (SR) in the Treatment of Adult Males With Attention-Deficit Hyperactivity Disorder: Complete Statistical AnalysisIndependent statistical analysis of Study of Flexible Doses of the Triple Reuptake Inhibitor EB-1020 Sustained Release (SR) in the Treatment of Adult Males With Attention-Deficit Hyperactivity Disorder: primary endpoint results, effect estimate…
- Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent Asthma: Complete Statistical AnalysisIndependent statistical analysis of Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study of Fluzone® Quadrivalent, Fluzone® Intradermal Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines in Adults: Complete Statistical AnalysisIndependent statistical analysis of Study of Fluzone® Quadrivalent, Fluzone® Intradermal Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines in Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of Fruquintinib in Patients With Metastatic Colorectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Fruquintinib in Patients With Metastatic Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02196688).